vs
Ascendis Pharma A/S（ASND）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是Ascendis Pharma A/S的1.7倍（$461.6M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 17.0%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 5.6%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
ASND vs RBC — 直观对比
营收规模更大
RBC
是对方的1.7倍
$267.3M
营收增速更快
ASND
高出25.3%
17.0%
两年增速更快
ASND
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $461.6M |
| 净利润 | — | $67.4M |
| 毛利率 | 90.5% | 44.3% |
| 营业利润率 | — | 22.3% |
| 净利率 | — | 14.6% |
| 营收同比 | 42.3% | 17.0% |
| 净利润同比 | — | 16.4% |
| 每股收益（稀释后） | — | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDRBC
| Q4 25 | $267.3M | $461.6M | ||
| Q3 25 | $230.7M | $455.3M | ||
| Q2 25 | $170.7M | $436.0M | ||
| Q1 25 | $109.0M | $437.7M | ||
| Q4 24 | $187.8M | $394.4M | ||
| Q3 24 | $62.5M | $397.9M | ||
| Q2 24 | $38.9M | $406.3M | ||
| Q1 24 | $103.6M | $413.7M |
净利润ASNDRBC
| Q4 25 | — | $67.4M | ||
| Q3 25 | $-65.9M | $60.0M | ||
| Q2 25 | $-42.0M | $68.5M | ||
| Q1 25 | $-102.2M | $72.7M | ||
| Q4 24 | — | $57.9M | ||
| Q3 24 | $-107.1M | $54.2M | ||
| Q2 24 | $-118.1M | $61.4M | ||
| Q1 24 | $-141.5M | — |
毛利率ASNDRBC
| Q4 25 | 90.5% | 44.3% | ||
| Q3 25 | 89.5% | 44.1% | ||
| Q2 25 | 80.1% | 44.8% | ||
| Q1 25 | 82.6% | 44.2% | ||
| Q4 24 | 91.9% | 44.3% | ||
| Q3 24 | 80.6% | 43.7% | ||
| Q2 24 | 68.2% | 45.3% | ||
| Q1 24 | 92.1% | 43.1% |
营业利润率ASNDRBC
| Q4 25 | — | 22.3% | ||
| Q3 25 | 5.1% | 21.5% | ||
| Q2 25 | -33.5% | 23.2% | ||
| Q1 25 | -103.2% | 23.0% | ||
| Q4 24 | — | 21.7% | ||
| Q3 24 | -167.3% | 21.6% | ||
| Q2 24 | -370.2% | 24.0% | ||
| Q1 24 | -51.2% | 22.8% |
净利率ASNDRBC
| Q4 25 | — | 14.6% | ||
| Q3 25 | -28.5% | 13.2% | ||
| Q2 25 | -24.6% | 15.7% | ||
| Q1 25 | -93.7% | 16.6% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | -171.5% | 13.6% | ||
| Q2 24 | -303.9% | 15.1% | ||
| Q1 24 | -136.6% | — |
每股收益（稀释后）ASNDRBC
| Q4 25 | — | $2.13 | ||
| Q3 25 | — | $1.90 | ||
| Q2 25 | — | $2.17 | ||
| Q1 25 | — | $2.33 | ||
| Q4 24 | — | $1.82 | ||
| Q3 24 | — | $1.65 | ||
| Q2 24 | — | $1.90 | ||
| Q1 24 | — | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $107.6M |
| 总债务越低越好 | — | $990.2M |
| 股东权益账面价值 | $-175.8M | $3.3B |
| 总资产 | $1.4B | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ASNDRBC
| Q4 25 | $665.3M | $107.6M | ||
| Q3 25 | $582.2M | $91.2M | ||
| Q2 25 | $533.6M | $132.9M | ||
| Q1 25 | $559.4M | $36.8M | ||
| Q4 24 | $604.3M | — | ||
| Q3 24 | $675.6M | — | ||
| Q2 24 | $279.4M | $76.8M | ||
| Q1 24 | $345.9M | $63.5M |
总债务ASNDRBC
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益ASNDRBC
| Q4 25 | $-175.8M | $3.3B | ||
| Q3 25 | $-188.0M | $3.2B | ||
| Q2 25 | $-202.6M | $3.1B | ||
| Q1 25 | $-205.0M | $3.0B | ||
| Q4 24 | $-114.2M | $2.9B | ||
| Q3 24 | $-105.1M | $2.9B | ||
| Q2 24 | $-346.8M | $2.8B | ||
| Q1 24 | $-257.2M | $2.8B |
总资产ASNDRBC
| Q4 25 | $1.4B | $5.1B | ||
| Q3 25 | $1.2B | $5.1B | ||
| Q2 25 | $1.2B | $4.8B | ||
| Q1 25 | $1.1B | $4.7B | ||
| Q4 24 | $1.3B | $4.7B | ||
| Q3 24 | $1.2B | $4.7B | ||
| Q2 24 | $819.0M | $4.7B | ||
| Q1 24 | $866.7M | $4.7B |
负债/权益比ASNDRBC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | — | $99.1M |
| 自由现金流率自由现金流/营收 | — | 21.5% |
| 资本支出强度资本支出/营收 | — | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDRBC
| Q4 25 | $58.2M | $122.1M | ||
| Q3 25 | — | $88.4M | ||
| Q2 25 | — | $120.0M | ||
| Q1 25 | $-15.5M | — | ||
| Q4 24 | $-330.7M | $84.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $97.4M | ||
| Q1 24 | $-109.7M | — |
自由现金流ASNDRBC
| Q4 25 | — | $99.1M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | — | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | — | — |
自由现金流率ASNDRBC
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 15.7% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | — |
资本支出强度ASNDRBC
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | — |
现金转化率ASNDRBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
